Repligen (RGEN) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.23% |
| Dec 31, 2025 | 6.61% |
| Sep 30, 2025 | 13.12% |
| Jun 30, 2025 | 13.39% |
| Mar 31, 2025 | 13.17% |
| Dec 31, 2024 | 13.23% |
| Sep 30, 2024 | 14.05% |
| Jun 30, 2024 | 17.69% |
| Mar 31, 2024 | 25.75% |
| Dec 31, 2023 | 26.13% |
| Sep 30, 2023 | 26.62% |
| Jun 30, 2023 | 26.73% |
| Mar 31, 2023 | 26.40% |
| Dec 31, 2022 | 26.43% |
| Sep 30, 2022 | 26.04% |
| Jun 30, 2022 | 56.72% |
| Mar 31, 2022 | 58.46% |
| Dec 31, 2021 | 59.64% |
| Sep 30, 2021 | 59.43% |
| Jun 30, 2021 | 57.82% |
| Mar 31, 2021 | 64.58% |
| Dec 31, 2020 | 65.61% |
| Sep 30, 2020 | 56.08% |
| Jun 30, 2020 | 56.22% |
| Mar 31, 2020 | 57.06% |
| Dec 31, 2019 | 56.82% |
| Sep 30, 2019 | 55.60% |
| Jun 30, 2019 | 50.05% |
| Mar 31, 2019 | 41.84% |
| Dec 31, 2018 | 48.89% |
| Sep 30, 2018 | 43.36% |
| Jun 30, 2018 | 45.30% |
| Mar 31, 2018 | 46.86% |
| Dec 31, 2017 | 47.71% |
| Sep 30, 2017 | 50.91% |
| Jun 30, 2017 | 22.67% |
| Mar 31, 2017 | 20.82% |
| Dec 31, 2016 | 20.66% |
| Sep 30, 2016 | 19.68% |
| Jun 30, 2016 | 19.45% |
| Mar 31, 2016 | 13.95% |
| Dec 31, 2015 | 12.84% |